Childhood stage IV Hodgkin disease: Therapeutic results of the Polish Pediatric Leukemia/Lymphoma Study Group

Armata, J; Balwierz, Walentyna; Moryl-Bujakowska, A; Bogusławska-Jaworska, J; Pisarek, J; Sońta-Jakimczyk, D; Janik-Moszant, A; Rokicka-Milewska, R; Sopyło, Barbara; Kołakowska-Mrozowska, Beatrycze; Kołecki, P; Kaczmarek-Kanold, M; Kowalczyk, Jerzy; Matysiak, Michał; Newecka-Samól, T

doi:10.1002/(sici)1096-911x(199910)33:4<382::aid-mpo7>3.0.co;2-7

Cited by 6 publications

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This demonstrated the first principle of treatment of unfavorable disease which is: combination of non-crossresistant chemotherapy improves outcome. In one example, the Polish Pediatric Leukemia/Lymphoma Study group examined a longitudinal series comparing a historic series of mechlorethamine, vinblastine, procarbazine, prednisone (MVPP) with more recent MVPP/ B-DOPA (bleomycin, dacarbazine, vincristine, prednisone, adriamycin), demonstrating superiority of the diverse regimen [24]. All current trials in intermediate and advanced stage Hodgkin lymphoma use a diverse and complex variety of agents.…”

Section: Stagingmentioning

confidence: 99%

Treatment of Pediatric Hodgkin Lymphoma

Olson¹,

Donaldson²

2008

Curr. Treat. Options in Oncol.

View full text Add to dashboard Cite

We are increasingly successful in the treatment of Hodgkin lymphoma. Current risk adapted trials seek to maintain the excellent efficacy of older therapies, while simultaneously limiting their late toxicities. Current management of early stage/favorable disease involves the use of two to four cycles of tailored chemotherapy, often followed by low-dose, involved field radiation. Those with intermediate and advanced stage disease require more intense chemotherapy and radiation regimens. Functional imaging using [(18)F]-2 fluoro-D-2-deoxyglucose is increasingly used to determine complete vs. partial response and to detect relapse. Given the success of primary therapy, retrieval of patients remains a highly individualized challenge. The majority of children failing combined-modality treatment undergo high-dose chemotherapy followed by autologous hematopoietic stem cell rescue, oftentimes with consolidative radiotherapy.

show abstract

Section: Stagingmentioning

confidence: 99%